Cargando…
IgA Nephropathy in the Setting of Anti-TNF-α Therapy for Inflammatory Bowel Disease
Tumor necrosis factor-α (TNF-α)-inhibiting agents are a standard therapy for moderate-to-severe inflammatory bowel disease (IBD). IgA nephropathy in the setting of prolonged exposure to TNF-α inhibitors is a rare, clinically significant adverse event often overlooked by gastroenterologists but well...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526714/ https://www.ncbi.nlm.nih.gov/pubmed/33062795 http://dx.doi.org/10.14309/crj.0000000000000462 |